TY - JOUR
T1 - Gender equality and gender norms
T2 - framing the opportunities for health
AU - Gender Equality, Norms, and Health Steering Committee
AU - Gupta, Geeta Rao
AU - Oomman, Nandini
AU - Grown, Caren
AU - Conn, Kathryn
AU - Hawkes, Sarah
AU - Shawar, Yusra Ribhi
AU - Shiffman, Jeremy
AU - Buse, Kent
AU - Mehra, Rekha
AU - Bah, Chernor A.
AU - Heise, Lori
AU - Greene, Margaret E.
AU - Weber, Ann M.
AU - Heymann, Jody
AU - Hay, Katherine
AU - Raj, Anita
AU - Henry, Sarah
AU - Klugman, Jeni
AU - Darmstadt, Gary L.
N1 - Funding Information:
The work of the Series was funded by the Gender Equality, Integrated Delivery, HIV, Nutrition, Family Planning, and Water Sanitation and Hygiene program strategy teams at the Bill & Melinda Gates Foundation and by the United Arab Emirates Ministry of Foreign Affairs and International Cooperation through grants to Stanford University received by GLD, or by sub-grants from Stanford to the United Nations Foundation and American University. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data and had final responsibility to submit the paper for publication. The views expressed are those of the authors and are not necessarily those of the Bill & Melinda Gates Foundation or the United Arab Emirates. KH is employed by the Bill & Melinda Gates Foundation. SHa is the co-founder and director of Global Health 50/50 and KB is the UNAIDS team representative to Global Health 50/50. LH is the technical director of the Prevention Collaborative. The other authors declare no competing interests.
Publisher Copyright:
© 2019 Elsevier Ltd
PY - 2019/6/22
Y1 - 2019/6/22
N2 - The Sustainable Development Goals offer the global health community a strategic opportunity to promote human rights, advance gender equality, and achieve health for all. The inability of the health sector to accelerate progress on a range of health outcomes brings into sharp focus the substantial impact of gender inequalities and restrictive gender norms on health risks and behaviours. In this paper, the fifth in a Series on gender equality, norms, and health, we draw on evidence to dispel three myths on gender and health and describe persistent barriers to progress. We propose an agenda for action to reduce gender inequality and shift gender norms for improved health outcomes, calling on leaders in national governments, global health institutions, civil society organisations, academic settings, and the corporate sector to focus on health outcomes and engage actors across sectors to achieve them; reform the workplace and workforce to be more gender-equitable; fill gaps in data and eliminate gender bias in research; fund civil-society actors and social movements; and strengthen accountability mechanisms.
AB - The Sustainable Development Goals offer the global health community a strategic opportunity to promote human rights, advance gender equality, and achieve health for all. The inability of the health sector to accelerate progress on a range of health outcomes brings into sharp focus the substantial impact of gender inequalities and restrictive gender norms on health risks and behaviours. In this paper, the fifth in a Series on gender equality, norms, and health, we draw on evidence to dispel three myths on gender and health and describe persistent barriers to progress. We propose an agenda for action to reduce gender inequality and shift gender norms for improved health outcomes, calling on leaders in national governments, global health institutions, civil society organisations, academic settings, and the corporate sector to focus on health outcomes and engage actors across sectors to achieve them; reform the workplace and workforce to be more gender-equitable; fill gaps in data and eliminate gender bias in research; fund civil-society actors and social movements; and strengthen accountability mechanisms.
UR - http://www.scopus.com/inward/record.url?scp=85067206634&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85067206634&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(19)30651-8
DO - 10.1016/S0140-6736(19)30651-8
M3 - Review article
C2 - 31155276
AN - SCOPUS:85067206634
VL - 393
SP - 2550
EP - 2562
JO - The Lancet
JF - The Lancet
SN - 0140-6736
IS - 10190
ER -